DOR BIOPHARMA INC of EWING, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-08. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 39 people.
| Name | Role | Location |
|---|---|---|
| Keith L Brownlie, CPA | Director | Princeton, NJ |
| Marco M Brughera, DVM | Director | Princeton, NJ |
| Gregg A LaPointe, CPA | Director | Princeton, NJ |
| Robert J Rubin, MD | Director | Princeton, NJ |
| Christopher J Schaber, PhD | Director | Princeton, NJ |
| Jerome B Zeldis, PhD | Director | Princeton, NJ |
| R. Christopher Cavalli, PhD | Executive Officer | Princeton, NJ |
| Oreola Christopher Donini, PhD | Executive Officer | Princeton, NJ |
| Karen Christopher Krumeich | Executive Officer | Princeton, NJ |
| Adam T Rumage | Executive Officer | Princeton, NJ |
| Christopher J Schaber, PhD | Executive Officer | Princeton, NJ |
| Richard C Straube, MD MSc | Executive Officer | Princeton, NJ |
| Jerome B Zeldis, M.D., Ph.D. | Director | South Plainfield, NJ |
| Brian Hamilton | Executive Officer | Richmond, VA |
| James Clavijo | Executive Officer | Miami, FL |
| Christopher J Schaber, Ph.D. | Director | Princeton, NJ |
| Christopher J Schaber, Ph.D. | Executive Officer | Princeton, NJ |
| Keith L Brownlie, C.P.A. | Director | Princeton, NJ |
| Gregg A Lapointe, C.P.A. | Director | Princeton, NJ |
| Joseph M Warusz, C.P.A. | Executive Officer | Princeton, NJ |
| Robert N Brey, Ph.D. | Executive Officer | Princeton, NJ |
| Kevin J Horgan, M.D. | Executive Officer | Princeton, NJ |
| Robert J Rubin, M.D. | Director | Princeton, NJ |
| Christopher P Schnittker, C.P.A. | Executive Officer | Princeton, NJ |
| Evan J Myrianthopoulos | Director | Princeton, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2013-05-03 | D | $1.5M | $1.5M |
| 2010-07-02 | D | $5.9M | $5.9M |
| 2009-03-24 | D | $400K | $300K |
| 2009-02-27 | D | $4.5M | $4.5M |
| 2009-02-03 | D | $2.4M | $2.4M |
| 2008-12-05 | D | $1.5M | $1.5M |